Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-25-016975
Filing Date
2025-10-06
Accepted
2025-10-06 08:08:57
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 263240
2 EX-5.1 ex5-1.htm EX-5.1 14764
3 EX-23.1 ex23-1.htm EX-23.1 3921
4 EX-23.2 ex23-2.htm EX-23.2 2733
5 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 31340
6 GRAPHIC forms-3_001.jpg GRAPHIC 8448
7 GRAPHIC ex5-1_001.jpg GRAPHIC 15365
  Complete submission text file 0001493152-25-016975.txt   481690

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 8259
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-290725 | Film No.: 251375672
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)